Overview

Duloxetine for the Treatment of Generalized Anxiety Disorder

Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
This is a 15 week study comparing how well duloxetine and placebo treatments improve generalized anxiety disorder
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Collaborator:
Boehringer Ingelheim
Treatments:
Duloxetine Hydrochloride